Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MODY probability calculator utility in individuals' selection for genetic testing: Its accuracy and performance. | Endocrinol Diabetes Metab | 2022 | 35822264 | PubTator, text mining | PubMed |
| Major Advances in Emerging Degrader Technologies. | Front Cell Dev Biol | 2022 | 35813205 | PubTator, text mining | PubMed |
| Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes. | Front Immunol | 2022 | 35812401 | PubTator, text mining | PubMed |
| Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells. | Front Immunol | 2022 | 35812378 | PubTator, text mining | PubMed |
| Dissecting the treatment-naive ecosystem of human melanoma brain metastasis. | Cell | 2022 | 35803246 | PubTator, text mining | PubMed |
| Sib-pair subgroup familial type 1 diabetes mellitus in children in the state of Qatar. | PLoS One | 2022 | 35802651 | PubTator, text mining | PubMed |
| Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 inhibitors. | J Enzyme Inhib Med Chem | 2022 | 35801486 | PubTator, text mining | PubMed |
| Genetic association and single-cell transcriptome analyses reveal distinct features connecting autoimmunity with cancers. | iScience | 2022 | 35800769 | PubTator, text mining | PubMed |
| Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways. | Front Immunol | 2022 | 35795661 | PubTator, text mining | PubMed |
| Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. | Nat Commun | 2022 | 35794096 | PubTator, text mining | PubMed |
| Performance of the Revised Classification Criteria for Systemic Autoimmune Rheumatic Diseases and Their Overlap Syndromes. | Intern Med | 2022 | 35781270 | PubTator, text mining | PubMed |
| A risk variant for Barrett's esophagus and esophageal adenocarcinoma at chr8p23.1 affects enhancer activity and implicates multiple gene targets. | Hum Mol Genet | 2022 | 35766871 | PubTator, text mining | PubMed |
| An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy. | ESMO Open | 2022 | 35759853 | PubTator, text mining | PubMed |
| Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy. | Cancer Immunol Res | 2022 | 35759797 | PubTator, text mining | PubMed |
| Differential regulation of CTLA4 expression through BTK-dependent and independent mechanisms in CLL. | Blood Adv | 2022 | 35759759 | PubTator, text mining | PubMed |
| The potential of pirtobrutinib in multiple B-cell malignancies. | Ther Adv Hematol | 2022 | 35747462 | PubTator, text mining | PubMed |
| Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways. | Life (Basel) | 2022 | 35743918 | PubTator, text mining | PubMed |
| Identification of a Unique Cytotoxic Thieno[2,3-c]Pyrazole Derivative with Potent and Selective Anticancer Effects In Vitro. | Biology (Basel) | 2022 | 35741451 | PubTator, text mining | PubMed |
| Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy. | Sci Adv | 2022 | 35731867 | PubTator, text mining | PubMed |
| IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting. | Nat Rev Rheumatol | 2022 | 35729334 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=23